Home > Drug Search >
  • Targets: Glycogen Synthase Kinase (GSK)
  •   > 
Drug Filter
Status:
Approved (15) Phase Ⅲ (1) Phase Ⅱ (14) Phase Ⅰ (10)
Clinical Stage:
Pending (5) Active (7) Discontinued (13)
Company:
Daiichi Sankyo (2) Genzyme (1) Johnson & Johnson (1) Kissei (1) Kyowa Hakko Kirin (1) Merck Serono (1) Merck Sharp & Dohme (1) Organon (1) Pfizer (3) Sanofi (1) Servier (1) SK biopharmaceuticals (1) Spectrum Pharmaceuticals (1) Takeda (2) Threshold (1) Unknown (6) University of North Carolina (1) Neurim Pharmaceuticals (1) Hikma (1) Wockhardt (2) Texas M. D. Anderson Cancer Center (1) Noscira (1) Moleculin (1) Heng Kang (1) Mediolanum Farmaceutici (1) Callisto (1) Ardana Bioscience (1) Mallinckrodt Pharmaceuticals (1) Abbott (2) Abbvie (1) AEterna Zentaris (1) Astellas (1) AstraZeneca (1) Bayer (2) Bristol-Myers Squibb (1)
Indication:
Acne (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Advanced prostate cancer (1) AIDS-related Kaposi’s sarcoma (1) Alzheimer's disease (AD) (1) Benign prostatic hypertrophy (1) Breast cancer (5) Rectal cancer (1) Precocious puberty in children (1) Chronic myeloid leukemia (CML ) (1) Bronchitis (1) Infections of the eye (1) Endometriosis (8) Gonorrhea (1) Leukemia (1) Lung cancer (1) Lymphoma (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (2) Parkinson's disease (PD) (1) Prostate cancer (8) Respiratory tract infection (1) Rheumatoid arthritis (RA) (1) Solid tumours (5) Urinary tract infections (2) Uterine fibroids (2) Uterine leiomyoma (2) Surgical infection (1) Pneumocystis pneumonia (1) Susceptible bacterial infections (2) Methicillin-resistant staphylococcus aureus infections (1) Biliary cancer (1) Infertility (5) Menstruation disorders (1) Bacterial infection (5) Complicated skin and soft tissue infections (1) Drug-induced dyskinesia (1) Infectious disease (1) Uterine disease (1)
Country:
Aprv. Year:
1996 (1) 2007 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top